143 related articles for article (PubMed ID: 38144556)
61. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.
Garvin MR; Alvarez C; Miller JI; Prates ET; Walker AM; Amos BK; Mast AE; Justice A; Aronow B; Jacobson D
Elife; 2020 Jul; 9():. PubMed ID: 32633718
[TBL] [Abstract][Full Text] [Related]
62. Analysis of Risk Factors in COVID-19 Adult Mortality in Russia.
Kirillov Y; Timofeev S; Avdalyan A; Nikolenko VN; Gridin L; Sinelnikov MY
J Prim Care Community Health; 2021; 12():21501327211008050. PubMed ID: 33829916
[TBL] [Abstract][Full Text] [Related]
63. Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage.
Deinhardt-Emmer S; Wittschieber D; Sanft J; Kleemann S; Elschner S; Haupt KF; Vau V; Häring C; Rödel J; Henke A; Ehrhardt C; Bauer M; Philipp M; Gaßler N; Nietzsche S; Löffler B; Mall G
Elife; 2021 Mar; 10():. PubMed ID: 33781385
[TBL] [Abstract][Full Text] [Related]
64. SARS-CoV-2 promotes RIPK1 activation to facilitate viral propagation.
Xu G; Li Y; Zhang S; Peng H; Wang Y; Li D; Jin T; He Z; Tong Y; Qi C; Wu G; Dong K; Gou J; Liu Y; Xiao T; Qu J; Li L; Liu L; Zhao P; Zhang Z; Yuan J
Cell Res; 2021 Dec; 31(12):1230-1243. PubMed ID: 34663909
[TBL] [Abstract][Full Text] [Related]
65. Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals.
Al-Kuraishy HM; Batiha GE; Faidah H; Al-Gareeb AI; Saad HM; Simal-Gandara J
Inflammopharmacology; 2022 Dec; 30(6):2017-2026. PubMed ID: 36044102
[TBL] [Abstract][Full Text] [Related]
66. A molecular single-cell lung atlas of lethal COVID-19.
Melms JC; Biermann J; Huang H; Wang Y; Nair A; Tagore S; Katsyv I; Rendeiro AF; Amin AD; Schapiro D; Frangieh CJ; Luoma AM; Filliol A; Fang Y; Ravichandran H; Clausi MG; Alba GA; Rogava M; Chen SW; Ho P; Montoro DT; Kornberg AE; Han AS; Bakhoum MF; Anandasabapathy N; Suárez-Fariñas M; Bakhoum SF; Bram Y; Borczuk A; Guo XV; Lefkowitch JH; Marboe C; Lagana SM; Del Portillo A; Tsai EJ; Zorn E; Markowitz GS; Schwabe RF; Schwartz RE; Elemento O; Saqi A; Hibshoosh H; Que J; Izar B
Nature; 2021 Jul; 595(7865):114-119. PubMed ID: 33915568
[TBL] [Abstract][Full Text] [Related]
67. Gene Networks of Hyperglycemia, Diabetic Complications, and Human Proteins Targeted by SARS-CoV-2: What Is the Molecular Basis for Comorbidity?
Saik OV; Klimontov VV
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806251
[TBL] [Abstract][Full Text] [Related]
68. Single-cell RNA sequencing analysis of human kidney reveals the presence of ACE2 receptor: A potential pathway of COVID-19 infection.
He Q; Mok TN; Yun L; He C; Li J; Pan J
Mol Genet Genomic Med; 2020 Oct; 8(10):e1442. PubMed ID: 32744436
[TBL] [Abstract][Full Text] [Related]
69. Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism.
Policard M; Jain S; Rego S; Dakshanamurthy S
Virus Res; 2021 Aug; 301():198464. PubMed ID: 34058265
[TBL] [Abstract][Full Text] [Related]
70. Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics.
Muus C; Luecken MD; Eraslan G; Sikkema L; Waghray A; Heimberg G; Kobayashi Y; Vaishnav ED; Subramanian A; Smillie C; Jagadeesh KA; Duong ET; Fiskin E; Torlai Triglia E; Ansari M; Cai P; Lin B; Buchanan J; Chen S; Shu J; Haber AL; Chung H; Montoro DT; Adams T; Aliee H; Allon SJ; Andrusivova Z; Angelidis I; Ashenberg O; Bassler K; Bécavin C; Benhar I; Bergenstråhle J; Bergenstråhle L; Bolt L; Braun E; Bui LT; Callori S; Chaffin M; Chichelnitskiy E; Chiou J; Conlon TM; Cuoco MS; Cuomo ASE; Deprez M; Duclos G; Fine D; Fischer DS; Ghazanfar S; Gillich A; Giotti B; Gould J; Guo M; Gutierrez AJ; Habermann AC; Harvey T; He P; Hou X; Hu L; Hu Y; Jaiswal A; Ji L; Jiang P; Kapellos TS; Kuo CS; Larsson L; Leney-Greene MA; Lim K; Litviňuková M; Ludwig LS; Lukassen S; Luo W; Maatz H; Madissoon E; Mamanova L; Manakongtreecheep K; Leroy S; Mayr CH; Mbano IM; McAdams AM; Nabhan AN; Nyquist SK; Penland L; Poirion OB; Poli S; Qi C; Queen R; Reichart D; Rosas I; Schupp JC; Shea CV; Shi X; Sinha R; Sit RV; Slowikowski K; Slyper M; Smith NP; Sountoulidis A; Strunz M; Sullivan TB; Sun D; Talavera-López C; Tan P; Tantivit J; Travaglini KJ; Tucker NR; Vernon KA; Wadsworth MH; Waldman J; Wang X; Xu K; Yan W; Zhao W; Ziegler CGK; ;
Nat Med; 2021 Mar; 27(3):546-559. PubMed ID: 33654293
[TBL] [Abstract][Full Text] [Related]
71. Comparison of infection risks and clinical outcomes in patients with and without SARS-CoV-2 lung infection under renin-angiotensin-aldosterone system blockade: Systematic review and meta-analysis.
Chu C; Zeng S; Hasan AA; Hocher CF; Krämer BK; Hocher B
Br J Clin Pharmacol; 2021 Jun; 87(6):2475-2492. PubMed ID: 33217033
[TBL] [Abstract][Full Text] [Related]
72. A single-cell transcriptomic landscape of the lungs of patients with COVID-19.
Wang S; Yao X; Ma S; Ping Y; Fan Y; Sun S; He Z; Shi Y; Sun L; Xiao S; Song M; Cai J; Li J; Tang R; Zhao L; Wang C; Wang Q; Zhao L; Hu H; Liu X; Sun G; Chen L; Pan G; Chen H; Li Q; Zhang P; Xu Y; Feng H; Zhao GG; Wen T; Yang Y; Huang X; Li W; Liu Z; Wang H; Wu H; Hu B; Ren Y; Zhou Q; Qu J; Zhang W; Liu GH; Bian XW
Nat Cell Biol; 2021 Dec; 23(12):1314-1328. PubMed ID: 34876692
[TBL] [Abstract][Full Text] [Related]
73. Effect of Comorbid Diabetes on Clinical Characteristics of COVID-19 Patients Infected by the Wild-Type or Delta Variant of SARS-CoV-2.
Zhang J; Zhang J; Tao Z
Front Endocrinol (Lausanne); 2022; 13():861443. PubMed ID: 35600601
[TBL] [Abstract][Full Text] [Related]
74. COVID-19 and Diabetes: A Comprehensive Review of Angiotensin Converting Enzyme 2, Mutual Effects and Pharmacotherapy.
Xie L; Zhang Z; Wang Q; Chen Y; Lu D; Wu W
Front Endocrinol (Lausanne); 2021; 12():772865. PubMed ID: 34867819
[TBL] [Abstract][Full Text] [Related]
75. Increased circulating microparticles contribute to severe infection and adverse outcomes of COVID-19 in patients with diabetes.
Sun H; Du Y; Kumar R; Buchkovich N; He P
Am J Physiol Heart Circ Physiol; 2022 Dec; 323(6):H1176-H1193. PubMed ID: 36269646
[TBL] [Abstract][Full Text] [Related]
76. The COVID-19 pandemic: a global health crisis.
Pollard CA; Morran MP; Nestor-Kalinoski AL
Physiol Genomics; 2020 Nov; 52(11):549-557. PubMed ID: 32991251
[TBL] [Abstract][Full Text] [Related]
77. Fulminant lung fibrosis in non-resolvable COVID-19 requiring transplantation.
Jyothula SSK; Peters A; Liang Y; Bi W; Shivshankar P; Yau S; Garcha PS; Yuan X; Akkanti B; Collum S; Wareing N; Thandavarayan RA; Poli de Frias F; Rosas IO; Zhao B; Buja LM; Eltzschig HK; Huang HJ; Karmouty-Quintana H
EBioMedicine; 2022 Dec; 86():104351. PubMed ID: 36375315
[TBL] [Abstract][Full Text] [Related]
78. Ovatodiolide inhibits SARS-CoV-2 replication and ameliorates pulmonary fibrosis through suppression of the TGF-β/TβRs signaling pathway.
Chiou WC; Huang GJ; Chang TY; Hsia TL; Yu HY; Lo JM; Fu PK; Huang C
Biomed Pharmacother; 2023 May; 161():114481. PubMed ID: 36906971
[TBL] [Abstract][Full Text] [Related]
79. SARS-CoV-2 Spike Proteins and Cell-Cell Communication Inhibits TFPI and Induces Thrombogenic Factors in Human Lung Microvascular Endothelial Cells and Neutrophils: Implications for COVID-19 Coagulopathy Pathogenesis.
Bhargavan B; Kanmogne GD
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142345
[TBL] [Abstract][Full Text] [Related]
80. Contribution of Host miRNA-223-3p to SARS-CoV-Induced Lung Inflammatory Pathology.
Morales L; Oliveros JC; Enjuanes L; Sola I
mBio; 2022 Apr; 13(2):e0313521. PubMed ID: 35229638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
